Senti Biosciences Ownership 2024 | Who Owns Senti Biosciences Now?

Overview RevenueFinancials Chart

Institutional Ownership

22.70%

Insider Ownership

21.02%

Retail Ownership

56.28%

Institutional Holders

19.00

Senti Biosciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
NEA MANAGEMENT COMPANY, LLC	9.68%	0.09%	4,426,151	-	-	1,221,618	Jun 30, 2024
8VC GP I, LLC	5.55%	8.67%	2,537,558	-	-	7,003,660	Jun 30, 2024
ARK INVESTMENT MANAGEMENT LLC	3.47%	0.00%	1,585,772	-45,150	-2.77%	437,673	Jun 30, 2024
VANGUARD GROUP INC	1.55%	-	707,052	-	-	195,146	Jun 30, 2024
INTEL CORP	1.30%	0.03%	595,665	-	-	164,404	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.54%	-	245,590	-	-	67,798	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	0.15%	-	69,751	-23,870	-25.50%	19,251	Jun 30, 2024
BLACKROCK INC.	0.09%	-	40,052	-	-	11,054	Jun 30, 2024
STATE STREET CORP	0.09%	-	39,100	-	-	10,792,000	Jun 30, 2024
NORTHERN TRUST CORP	0.08%	-	36,848	-	-	10,170,000	Jun 30, 2024
ALLEN OPERATIONS LLC	0.05%	0.00%	21,443	-	-	5,918	Jun 30, 2024
TRIATOMIC MANAGEMENT LP	0.03%	0.13%	15,493	-295,040	-95.01%	4,276	Jun 30, 2024
HRT FINANCIAL LP	0.03%	-	12,513	12,513	100.00%	3,000	Jun 30, 2024
MORGAN STANLEY	0.01%	-	5,396	3,796	237.25%	1,490	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	-	3,823	-4,691	-55.10%	1,055	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	820	579	240.25%	227	Jun 30, 2024
WOLVERINE ASSET MANAGEMENT LLC	0.00%	-	800	-	-	220	Jun 30, 2024
TORONTO DOMINION BANK	0.00%	-	37	-	-	102	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-202	-100.00%	-	Jun 30, 2024
HARBOUR INVESTMENTS, INC.	-	-	-	-15,000	-100.00%	-	Jun 30, 2024

Senti Biosciences's largest institutional shareholder is NEA MANAGEMENT COMPANY, LLC, holding 9.68% of the company's total share outstanding, currently valued at $1.22M. The top 10 institutional shareholders own together 22.50% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
8VC GP I, LLC	5.55%	8.67%	2,537,558	-	-	7,003,660	Jun 30, 2024
TRIATOMIC MANAGEMENT LP	0.03%	0.13%	15,493	-295,040	-95.01%	4,276	Jun 30, 2024
NEA MANAGEMENT COMPANY, LLC	9.68%	0.09%	4,426,151	-	-	1,221,618	Jun 30, 2024
INTEL CORP	1.30%	0.03%	595,665	-	-	164,404	Jun 30, 2024
ARK INVESTMENT MANAGEMENT LLC	3.47%	0.00%	1,585,772	-45,150	-2.77%	437,673	Jun 30, 2024
ALLEN OPERATIONS LLC	0.05%	0.00%	21,443	-	-	5,918	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	0.15%	-	69,751	-23,870	-25.50%	19,251	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	-	3,823	-4,691	-55.10%	1,055	Jun 30, 2024
HRT FINANCIAL LP	0.03%	-	12,513	12,513	100.00%	3,000	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.54%	-	245,590	-	-	67,798	Jun 30, 2024
VANGUARD GROUP INC	1.55%	-	707,052	-	-	195,146	Jun 30, 2024
WOLVERINE ASSET MANAGEMENT LLC	0.00%	-	800	-	-	220	Jun 30, 2024
NORTHERN TRUST CORP	0.08%	-	36,848	-	-	10,170,000	Jun 30, 2024
STATE STREET CORP	0.09%	-	39,100	-	-	10,792,000	Jun 30, 2024
BLACKROCK INC.	0.09%	-	40,052	-	-	11,054	Jun 30, 2024
TORONTO DOMINION BANK	0.00%	-	37	-	-	102	Jun 30, 2024
MORGAN STANLEY	0.01%	-	5,396	3,796	237.25%	1,490	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	820	579	240.25%	227	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-202	-100.00%	-	Jun 30, 2024
HARBOUR INVESTMENTS, INC.	-	-	-	-15,000	-100.00%	-	Jun 30, 2024

The largest Senti Biosciences shareholder by % of total assets is 8VC GP I, LLC. The company owns 2.54M shares of Senti Biosciences (SNTI), representing 8.67% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
HRT FINANCIAL LP	0.03%	-	12,513	12,513	100.00%	3,000	Jun 30, 2024
MORGAN STANLEY	0.01%	-	5,396	3,796	237.25%	1,490	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	820	579	240.25%	227	Jun 30, 2024
TORONTO DOMINION BANK	0.00%	-	37	-	-	102	Jun 30, 2024
BLACKROCK INC.	0.09%	-	40,052	-	-	11,054	Jun 30, 2024
STATE STREET CORP	0.09%	-	39,100	-	-	10,792,000	Jun 30, 2024
NORTHERN TRUST CORP	0.08%	-	36,848	-	-	10,170,000	Jun 30, 2024
WOLVERINE ASSET MANAGEMENT LLC	0.00%	-	800	-	-	220	Jun 30, 2024
VANGUARD GROUP INC	1.55%	-	707,052	-	-	195,146	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.54%	-	245,590	-	-	67,798	Jun 30, 2024
ALLEN OPERATIONS LLC	0.05%	0.00%	21,443	-	-	5,918	Jun 30, 2024
INTEL CORP	1.30%	0.03%	595,665	-	-	164,404	Jun 30, 2024
NEA MANAGEMENT COMPANY, LLC	9.68%	0.09%	4,426,151	-	-	1,221,618	Jun 30, 2024
8VC GP I, LLC	5.55%	8.67%	2,537,558	-	-	7,003,660	Jun 30, 2024
COMERICA BANK	-	-	-	-48	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-202	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-732	-100.00%	-	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	-	3,823	-4,691	-55.10%	1,055	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	-	-	-	-13,337	-100.00%	-	Jun 30, 2024
HARBOUR INVESTMENTS, INC.	-	-	-	-15,000	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Senti Biosciences's largest institutional buyer is HRT FINANCIAL LP. The company purchased 12.51K stocks of SNTI, valued at $3.00K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TRIATOMIC MANAGEMENT LP	0.03%	0.13%	15,493	-295,040	-95.01%	4,276	Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	-	-	-	-145,000	-100.00%	-	Jun 30, 2024
ARK INVESTMENT MANAGEMENT LLC	3.47%	0.00%	1,585,772	-45,150	-2.77%	437,673	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-24,102	-100.00%	-	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	0.15%	-	69,751	-23,870	-25.50%	19,251	Jun 30, 2024
VIRTU FINANCIAL LLC	-	-	-	-19,678	-100.00%	-	Jun 30, 2024
HARBOUR INVESTMENTS, INC.	-	-	-	-15,000	-100.00%	-	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	-	-	-	-13,337	-100.00%	-	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	-	3,823	-4,691	-55.10%	1,055	Jun 30, 2024
UBS GROUP AG	-	-	-	-732	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-202	-100.00%	-	Jun 30, 2024
COMERICA BANK	-	-	-	-48	-100.00%	-	Jun 30, 2024
8VC GP I, LLC	5.55%	8.67%	2,537,558	-	-	7,003,660	Jun 30, 2024
NEA MANAGEMENT COMPANY, LLC	9.68%	0.09%	4,426,151	-	-	1,221,618	Jun 30, 2024
INTEL CORP	1.30%	0.03%	595,665	-	-	164,404	Jun 30, 2024
ALLEN OPERATIONS LLC	0.05%	0.00%	21,443	-	-	5,918	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.54%	-	245,590	-	-	67,798	Jun 30, 2024
VANGUARD GROUP INC	1.55%	-	707,052	-	-	195,146	Jun 30, 2024
WOLVERINE ASSET MANAGEMENT LLC	0.00%	-	800	-	-	220	Jun 30, 2024
NORTHERN TRUST CORP	0.08%	-	36,848	-	-	10,170,000	Jun 30, 2024

As of Jun 30 2024, Senti Biosciences's biggest institutional seller is TRIATOMIC MANAGEMENT LP. The company sold -0.30M shares of SNTI, valued at $4.28K.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
HRT FINANCIAL LP	0.03%	-	12,513	12,513	100.00%	3,000	Jun 30, 2024

Senti Biosciences's largest new institutional shareholder by number of shares is HRT FINANCIAL LP, purchased 12.51K shares, valued at $3.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BRIDGEWAY CAPITAL MANAGEMENT, LLC	-	-	-	-145,000	-100.00%	-	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-24,102	-100.00%	-	Jun 30, 2024
VIRTU FINANCIAL LLC	-	-	-	-19,678	-100.00%	-	Jun 30, 2024
HARBOUR INVESTMENTS, INC.	-	-	-	-15,000	-100.00%	-	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	-	-	-	-13,337	-100.00%	-	Jun 30, 2024
UBS GROUP AG	-	-	-	-732	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-202	-100.00%	-	Jun 30, 2024
COMERICA BANK	-	-	-	-48	-100.00%	-	Jun 30, 2024

Senti Biosciences's largest sold out institutional shareholder by shares sold is BRIDGEWAY CAPITAL MANAGEMENT, LLC, sold -0.14M shares, valued at -, as of undefined.

Senti Biosciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
T. Rowe Price Health Sciences Fund, Inc.	0.34%	1,121,315	-	-	Mar 31, 2024
T. Rowe Price New Horizons Fund, Inc.	0.28%	1,389,887	-	-	Mar 31, 2024
Ark ETF Trust	0.21%	1,661,853	-120,161	-6.74%	Jan 31, 2024
BRIDGEWAY FUNDS INC	0.06%	145,000	-	-	Mar 28, 2024
T. Rowe Price Equity Series, Inc.	0.04%	63,936	-	-	Mar 31, 2024
MORGAN STANLEY INSTITUTIONAL FUND INC	0.01%	376,858	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	707,052	-386,899	-35.37%	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	229,867	6,211	2.78%	Feb 29, 2024
ETF Series Solutions	0.00%	2,275	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	29,595	-	-	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	2,834	-	-	Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	18,231	-	-	Mar 31, 2024
MASSMUTUAL SELECT FUNDS	0.00%	5,711	-	-	Dec 31, 2023
John Hancock Funds II	0.00%	26,772	-	-	Feb 29, 2024

Senti Biosciences's largest mutual fund holder by % of total assets is "T. Rowe Price Health Sciences Fund, Inc.", owning 1.12M shares, compromising 0.34% of its total assets.

Senti Biosciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	19	-29.63%
31 Mar, 24	27	8.00%
31 Dec, 23	25	4.17%
30 Sep, 23	24	-14.29%
30 Jun, 23	28	16.67%
31 Mar, 23	24	-7.69%
31 Dec, 22	26	13.04%
30 Sep, 22	23	27.78%
30 Jun, 22	18	-

As of 30 Jun 24, 19 institutions are holding Senti Biosciences's shares, representing a decrease of -29.63% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	10,375,264	-5.63%
31 Mar, 24	10,994,171	-4.07%
31 Dec, 23	11,461,121	-4.80%
30 Sep, 23	12,038,399	-1.33%
30 Jun, 23	12,201,253	-3.24%
31 Mar, 23	12,610,070	1.67%
31 Dec, 22	12,403,151	-7.91%
30 Sep, 22	13,468,041	13.14%
30 Jun, 22	11,903,638	-

Senti Biosciences (SNTI) has 10.38M shares outstanding as of 30 Jun 24, down -5.63% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	22.70%	3.75%
31 Mar, 24	24.62%	3.71%
31 Dec, 23	25.77%	3.49%
30 Sep, 23	27.19%	3.55%
30 Jun, 23	27.69%	3.38%
31 Mar, 23	28.61%	3.57%
31 Dec, 22	28.30%	3.00%
30 Sep, 22	30.73%	0.39%
30 Jun, 22	88.53%	-

As of 30 Jun 24, Senti Biosciences is held by 22.70% institutional shareholders, representing a 3.75% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	4	-63.64%
31 Mar, 24	11	10.00%
31 Dec, 23	10	25.00%
30 Sep, 23	8	-33.33%
30 Jun, 23	12	100.00%
31 Mar, 23	6	-45.45%
31 Dec, 22	11	-26.67%
30 Sep, 22	15	-16.67%
30 Jun, 22	18	-

4 institutional shareholders have increased their position in SNTI stock as of 30 Jun 24 compared to 11 in the previous quarter (a -63.64% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	4	33.33%
31 Mar, 24	3	200.00%
31 Dec, 23	1	-66.67%
30 Sep, 23	3	-25.00%
30 Jun, 23	4	-
31 Mar, 23	4	-60.00%
31 Dec, 22	10	900.00%
30 Sep, 22	1	-
30 Jun, 22	-	-

4 institutional shareholders have reduced their position in SNTI stock as of 30 Jun 24 compared to 3 in the previous quarter (a 33.33% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	19	-29.63%	10,375,264	-5.63%	22.70%	3.75%	4	-63.64%	4	33.33%
31 Mar, 24	27	8.00%	10,994,171	-4.07%	24.62%	3.71%	11	10.00%	3	200.00%
31 Dec, 23	25	4.17%	11,461,121	-4.80%	25.77%	3.49%	10	25.00%	1	-66.67%
30 Sep, 23	24	-14.29%	12,038,399	-1.33%	27.19%	3.55%	8	-33.33%	3	-25.00%
30 Jun, 23	28	16.67%	12,201,253	-3.24%	27.69%	3.38%	12	100.00%	4	-
31 Mar, 23	24	-7.69%	12,610,070	1.67%	28.61%	3.57%	6	-45.45%	4	-60.00%
31 Dec, 22	26	13.04%	12,403,151	-7.91%	28.30%	3.00%	11	-26.67%	10	900.00%
30 Sep, 22	23	27.78%	13,468,041	13.14%	30.73%	0.39%	15	-16.67%	1	-
30 Jun, 22	18	-	11,903,638	-	88.53%	-	18	-	-	-

Senti Biosciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Feb 13, 2023	BAYER HEALTHCARE LLC	10 percent owner	-		Sell	-	-	-	5,878,488

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 12, 2024	Mathers Edward T	director	-	A-Award	Buy	62,500	$0.31	$19.38K	62,500
Jul 12, 2024	Farokhzad Omid	director	-	A-Award	Buy	62,500	$0.31	$19.38K	62,500
Jul 12, 2024	Collins James J.	director	-	A-Award	Buy	62,500	$0.31	$19.38K	62,500
Jul 12, 2024	COOPERSTONE BRENDA	director	-	A-Award	Buy	62,500	$0.31	$19.38K	62,500
May 09, 2024	Li Yvonne	officer	-		Buy	-	-	-	-
Feb 02, 2024	Rajangam Kanya	officer	Chief Medical & Devt. Officer	A-Award	Buy	152,000	$0.46	$69.92K	152,000
Feb 02, 2024	Rajangam Kanya	officer	Chief Medical & Devt. Officer	A-Award	Buy	101,000	-	-	101,000
Feb 02, 2024	Lu Timothy K	director, officer	CEO and President	A-Award	Buy	306,000	-	-	865,496
Feb 02, 2024	Lu Timothy K	director, officer	CEO and President	A-Award	Buy	459,000	$0.46	$211.14K	459,000
Feb 02, 2024	KNOBELMAN DEBORAH	officer, other	Chief Financial Officer	A-Award	Buy	152,000	$0.46	$69.92K	152,000
Feb 02, 2024	KNOBELMAN DEBORAH	officer, other	Chief Financial Officer	A-Award	Buy	101,000	-	-	131,000
Jun 21, 2023	Mathers Edward T	director	-	A-Award	Buy	62,500	$0.99	$61.88K	62,500
Jun 21, 2023	Berland Susan D	director	-	A-Award	Buy	62,500	$0.99	$61.88K	62,500
Jun 21, 2023	Collins James J.	director	-	A-Award	Buy	62,500	$0.99	$61.88K	62,500
Jun 21, 2023	COOPERSTONE BRENDA	director	-	A-Award	Buy	62,500	$0.99	$61.88K	62,500
Jun 21, 2023	Farokhzad Omid	director	-	A-Award	Buy	62,500	$0.99	$61.88K	62,500
Feb 13, 2023	BAYER HEALTHCARE LLC	10 percent owner	-		Sell	-	-	-	5,878,488
Feb 02, 2023	Lee Philip J	officer	Chief Technology Officer	A-Award	Buy	195,000	$1.81	$352.95K	195,000
Feb 02, 2023	KNOBELMAN DEBORAH	officer	Chief Financial Officer	A-Award	Buy	130,000	$1.81	$235.30K	130,000
Feb 02, 2023	Rajangam Kanya	officer	Chief Medical & Devt. Officer	A-Award	Buy	130,000	$1.81	$235.30K	130,000

The last insider sell of Senti Biosciences's stock was made by BAYER HEALTHCARE LLC on Feb 13 2023, selling - shares at - per share (valued at -).

Senti Biosciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	4	-	-
Q2 2024	-	-	-
Q1 2024	6	-	-
Q2 2023	5	-	-
Q1 2023	4	-	-
Q4 2022	2	-	-
Q3 2022	10	-	-
Q2 2022	2	23	8.70%
Q2 2021	-	2	-
Q2 2014	14	2	700.00%
Q4 2013	1	-	-
Q3 2013	7	-	-
Q2 2013	5	-	-
Q1 2013	4	-	-

4 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Senti Biosciences's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	-	-	-
Q2 2024	-	-	-
Q1 2024	-	-	-
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q2 2021	-	-	-
Q2 2014	-	-	-
Q4 2013	1	-	-
Q3 2013	-	-	-
Q2 2013	1	-	-
Q1 2013	-	-	-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Senti Biosciences's stocks.

Senti Biosciences Peer Ownership

Ticker	Company
BLCM	Bellicum Pharmaceuticals, Inc.
MNPR	Monopar Therapeutics Inc.
FHTX	Foghorn Therapeutics Inc.
MLYS	Mineralys Therapeutics, Inc.
SABS	SAB Biotherapeutics, Inc.
CVKD	Cadrenal Therapeutics, Inc. Common Stock
QNRX	Quoin Pharmaceuticals, Ltd.
FENC	Fennec Pharmaceuticals Inc.
HILS	Tharimmune, Inc.
TYRA	Tyra Biosciences, Inc.
CING	Cingulate Inc.
CNTB	Connect Biopharma Holdings Limited
XLO	Xilio Therapeutics, Inc.
LIPO	Lipella Pharmaceuticals Inc.
NLTX	Neurogene Inc.
RAPT	RAPT Therapeutics, Inc.

SNTI Ownership FAQ

Who Owns Senti Biosciences?

Senti Biosciences is owned by institutional shareholders (22.70%), insiders (21.02%), and public (56.28%). The largest institutional shareholder of Senti Biosciences is NEA MANAGEMENT COMPANY, LLC (9.68% of total shares) and the top mutual fund owner is T. Rowe Price Health Sciences Fund, Inc. (0.34% of total shares).

Who are the major institutional shareholders of Senti Biosciences?

Senti Biosciences's major institutional shareholders are NEA MANAGEMENT COMPANY, LLC, 8VC GP I, LLC, ARK INVESTMENT MANAGEMENT LLC, VANGUARD GROUP INC, and INTEL CORP. The top five shareholders own together 21.55% of the company's share outstanding.

How many Senti Biosciences shareholders are there?

As of Jun 2024, there are 19 institutional shareholders of Senti Biosciences.

What percentage of Senti Biosciences is owned by NEA MANAGEMENT COMPANY, LLC?

NEA MANAGEMENT COMPANY, LLC owns 4.43M shares of Senti Biosciences, representing 9.68% of the company's total shares outstanding, valued at $1.22M (as of Jun 2024).

What percentage of Senti Biosciences is owned by 8VC GP I, LLC?

As of Jun 2024, 8VC GP I, LLC holds 2.54M shares of Senti Biosciences (SNTI), compromising 5.55% of the company, valued at $7M.

What percentage of Senti Biosciences is owned by ARK INVESTMENT MANAGEMENT LLC?

ARK INVESTMENT MANAGEMENT LLC is the third largest holder of Senti Biosciences. The company owns 1.59M of the company's shares outstanding (worth $437.67K).